9 results
·
27ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: Class I
×
ECMO Reinforced Dual Lumen Cannula, Sterile EO, Rx Only, REF: VV28F
FDA Enforcement
Class I
·Terminated·OriGen Biomedical, Inc.·June 12, 2019
ECMO Reinforced Dual Lumen Cannula, Sterile EO, Rx Only, REF: VV16F
FDA Enforcement
Class I
·Terminated·OriGen Biomedical, Inc.·June 12, 2019
ECMO Reinforced Dual Lumen Cannula, Sterile EO, Rx Only, REF: VV23F
FDA Enforcement
Class I
·Terminated·OriGen Biomedical, Inc.·June 12, 2019
ECMO Reinforced Dual Lumen Cannula, Sterile EO, Rx Only, REF: VV32F
FDA Enforcement
Class I
·Terminated·OriGen Biomedical, Inc.·June 12, 2019
ECMO Reinforced Dual Lumen Cannula, Sterile EO, Rx Only, REF: VV19F
FDA Enforcement
Class I
·Terminated·OriGen Biomedical, Inc.·June 12, 2019
ECMO Reinforced Dual Lumen Cannula, Sterile EO, Rx Only, REF: VV13F
FDA Enforcement
Class I
·Terminated·OriGen Biomedical, Inc.·June 12, 2019
OriGen BIOMEDICAL VV13F Reinforced Dual Lumen Catheter STERILE DISPOSABLE: DO NOT RE-USE Manufactured by: OriGen Biomedical. OriGene VV13F Reinforced Dual Lumen Catheter indicated for use as a single cannula for both venous drainage and re-infusion of blood in the internal jugular vein during extracorporeal life support procedures of six hours or less.
FDA Enforcement
Class I
·Terminated·OriGen Biomedical, Inc.·April 29, 2015
REF VV19F Reinforced Dual Lumen Cannula, 19Fr., Sterile EO, DISPOSABLE: DO NOT RE-USE CE 0473 Product Usage: The OriGen RDLC catheter is indicated for use as a single cannula for both venous drainage and arterial re-infusion of blood in the internal jugular vein during extracorporeal life support procedures of six hours or less.
FDA Enforcement
Class I
·Terminated·OriGen Biomedical, Inc.·November 14, 2018
The OriGen Reinforced Dual Lumen catheter (RDLC) is a duel lumen catheter with a wire reinforcement layer on the tip of the device. A thin sheath is used to cover and secure the wire layer and is heat shrunk into a permanent position.
FDA Enforcement
Class I
·Terminated·OriGen Biomedical, Inc.·November 1, 2017